Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The UK Government and biotech company Valneva are set to make a joint investment in a manufacturing facility in Livingston, West Lothian as part of an agreement for early access to 60 million doses of the company’s Covid-19 vaccine candidate.
The investment will boost vaccine manufacturing capacity Valneva’s Livingston site and support the jobs of more than 100 scientists and technicians.
Currently, more than 100 employees are working at the facility, with a quarter directly involved in coronavirus vaccine manufacturing.